Structures by: Yathirajan H. S.
Total: 746
3-(2-Bromo-5-methoxyphenyl)-5-methyl-1-(4-phenyl-1,3-thiazol-2-yl)- 1H-1,2,4-triazole
C19H15BrN4OS
Acta Crystallographica Section E (2006) 62, 11 o5013-o5014
a=11.9585(7)Å b=5.0552(3)Å c=29.0105(15)Å
α=90.00° β=90.863(5)° γ=90.00°
(2E)-3-(1,3-Benzodioxol-5-yl)-1-(4-bromophenyl)prop-2-en-1-one
C16H11BrO3
Acta Crystallographica Section E (2006) 62, 11 o5293-o5295
a=3.9221(2)Å b=10.9795(8)Å c=29.840(2)Å
α=90.00° β=90.299(4)° γ=90.00°
(2E)-3-(4-Butoxyphenyl)-1-(4-chlorophenyl)prop-2-en-1-one
C19H19ClO2
Acta Crystallographica Section E (2006) 62, 12 o5923-o5924
a=5.9580(6)Å b=11.6745(12)Å c=12.6433(12)Å
α=106.346(9)° β=94.975(7)° γ=103.112(8)°
4-(Methylsulfanyl)benzaldehyde thiosemicarbazone
C9H11N3S2
Acta Crystallographica Section E (2006) 62, 12 o5925-o5926
a=8.2052(4)Å b=9.1947(5)Å c=15.5994(8)Å
α=106.558(5)° β=97.573(3)° γ=100.110(4)°
(R,S)-3-ethyl 5-methyl 2-(2-ammonioethoxymethyl)4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine- 3,5-dicarboxylate methanesulfonate hydrate
C20H26ClN2O5,CH3O3S,H2O
Acta Crystallographica Section E (2006) 62, 12 o5814-o5816
a=47.656(11)Å b=11.069(2)Å c=9.848(2)Å
α=90.00° β=99.560(6)° γ=90.00°
2-Bromo-N'-[(1E)-(4-fluorophenyl)methylene]-5-methoxybenzohydrazide monohydrate
C15H12BrFN2O2,H2O
Acta Crystallographica Section E (2007) 63, 6 o2948-o2948
a=30.1171(18)Å b=8.0187(7)Å c=13.4661(8)Å
α=90.00° β=111.902(4)° γ=90.00°
1,5-Bis(3-bromothien-2-yl)-3-(3-nitrophenyl)pentane-1,5-dione
C19H13Br2NO4S2
Acta Crystallographica Section E (2006) 62, 10 o4554-o4555
a=17.5329(13)Å b=15.6345(9)Å c=7.4723(6)Å
α=90.00° β=96.932(6)° γ=90.00°
5-(2-Bromo-5-methoxyphenyl)-1,3,4-oxadiazol-2-amine
C9H8BrN3O2
Acta Crystallographica Section E (2006) 62, 10 o4442-o4443
a=18.1501(19)Å b=10.3513(7)Å c=11.0955(10)Å
α=90.00° β=95.298(8)° γ=90.00°
3-(6-Methoxy-2-naphthyl)-1-(2-thienyl)prop-2-en-1-one
C18H14O2S
Acta Crystallographica Section E (2006) 62, 10 o4440-o4441
a=3.9155(3)Å b=10.6776(8)Å c=33.521(3)Å
α=90.00° β=93.164(7)° γ=90.00°
2-(2-Bromo-5-methoxyphenyl)-6-phenyl-1,3-thiazolo[3,2-b][1,2,4]triazole
C17H12BrN3OS
Acta Crystallographica Section E (2006) 62, 10 o4444-o4445
a=14.9271(13)Å b=10.9247(13)Å c=18.8582(16)Å
α=90.00° β=90.00° γ=90.00°
2-Hydroxy-3,5-diisopropylbenzoic acid
C13H18O3
Acta Crystallographica Section E (2006) 62, 10 o4255-o4257
a=9.2545(7)Å b=14.7627(13)Å c=15.2767(12)Å
α=72.823(7)° β=78.217(6)° γ=76.792(7)°
3-[4-(Methylsulfanyl)phenyl]-1-(4-nitrophenyl)prop-2-en-1-one
C16H13NO3S
Acta Crystallographica Section E (2006) 62, 10 o4508-o4509
a=13.7388(4)Å b=33.5802(8)Å c=5.9538(2)Å
α=90.00° β=90.00° γ=90.00°
5-Fluoro-1H-indole-2-carbohydrazide
C9H8FN3O
Acta Crystallographica Section E (2006) 62, 11 o4986-o4988
a=10.0451(3)Å b=9.4978(2)Å c=18.5293(6)Å
α=90.00° β=90.00° γ=90.00°
1,5-Bis(4-bromophenyl)-3-(3-nitrophenyl)pentane-1,5-dione
C23H17Br2NO4
Acta Crystallographica Section E (2007) 63, 1 o228-o229
a=21.3111(10)Å b=9.3462(5)Å c=22.3385(16)Å
α=90.00° β=90.00° γ=90.00°
(2E)-1-(2,4-Dichlorophenyl)-3-[4-(methylsulfanyl)phenyl]prop-2-en-1-one
C16H12Cl2OS
Acta Crystallographica Section E (2007) 63, 1 o30-o32
a=12.957(3)Å b=3.8920(8)Å c=14.135(3)Å
α=90.00° β=97.736(2)° γ=90.00°
5-Phenyl-1-(2-thienyl)penta-2,4-dien-1-one
C15H12OS
Acta Crystallographica Section E (2007) 63, 1 o61-o62
a=15.5571(12)Å b=10.2136(7)Å c=15.8883(11)Å
α=90.00° β=90.00° γ=90.00°
N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide
C12H9F3N2O2
Acta Crystallographica Section E (2007) 63, 1 o33-o35
a=10.2636(5)Å b=11.5179(6)Å c=10.4182(5)Å
α=90.00° β=102.9440(10)° γ=90.00°
1-(3-Bromo-2-thienyl)-3-[4-(dimethylamino)phenyl]prop-2-en-1-one
C15H14BrNOS
Acta Crystallographica Section E (2007) 63, 2 o1005-o1007
a=9.6866(3)Å b=12.6923(4)Å c=12.8555(5)Å
α=94.4440(10)° β=101.6730(10)° γ=107.3220(10)°
(E)-2-Hydroxy-5-methyl-3-[(4-methyl-2-pyridyl)iminomethyl]benzaldehyde
C15H14N2O2
Acta Crystallographica Section E (2007) 63, 4 o1996-o1998
a=7.4936(7)Å b=4.5019(3)Å c=20.677(2)Å
α=90.00° β=109.273(7)° γ=90.00°
2,3-Dibromo-1-(2,4-dichlorophenyl)-3-(4,5-dimethoxy-2-nitrophenyl)propan-1-one
C17H13Br2Cl2NO5
Acta Crystallographica Section E (2007) 63, 5 o2196-o2197
a=13.7847(4)Å b=18.7740(5)Å c=29.8756(10)Å
α=90.00° β=90.00° γ=90.00°
2,3-Dibromo-1-(3-bromo-2-thienyl)-3-(4-fluorophenyl)propan-1-one
C13H8Br3FOS
Acta Crystallographica Section E (2007) 63, 5 o2198-o2199
a=11.8008(14)Å b=7.5062(8)Å c=16.758(2)Å
α=90.00° β=104.010(9)° γ=90.00°
N-(2-Nitro-4-propoxyphenyl)acetamide
C11H14N2O4
Acta Crystallographica Section E (2007) 63, 5 o2202-o2203
a=16.9055(15)Å b=4.0057(2)Å c=18.0989(16)Å
α=90.00° β=111.490(7)° γ=90.00°
(2E)-3-(4-Chlorophenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one
C15H11ClO2
Acta Crystallographica Section E (2007) 63, 8 o3661-o3661
a=7.5910(7)Å b=10.8509(7)Å c=15.1544(11)Å
α=90.00° β=104.213(8)° γ=90.00°
(2E)-1-(3-Hydroxyphenyl)-3-(4-methylphenyl)prop-2-en-1-one
C16H14O2
Acta Crystallographica Section E (2007) 63, 8 o3660-o3660
a=7.6363(5)Å b=11.0786(5)Å c=15.2355(8)Å
α=90.00° β=104.038(6)° γ=90.00°
7-Hydroxy-4-methyl-2<i>H</i>-chromen-2-one monohydrate
C10H8O3,H2O
Acta Crystallographica Section E (2007) 63, 8 o3412-o3413
a=6.9508(5)Å b=11.3074(8)Å c=11.7833(8)Å
α=90.00° β=105.6430(10)° γ=90.00°
2,4-Diacetylquinoline
C13H11NO2
Acta Crystallographica Section E (2007) 63, 8 o3557-o3557
a=7.5285(6)Å b=15.0366(12)Å c=9.7202(7)Å
α=90.00° β=105.704(9)° γ=90.00°
(2E)-3-(4-Fluorophenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one
C15H11FO2
Acta Crystallographica Section E (2007) 63, 8 o3586-o3586
a=7.4149(4)Å b=11.3162(6)Å c=14.7472(8)Å
α=90.00° β=104.311(6)° γ=90.00°
1-(Quinolin-2-yl)ethanone
C11H9NO
Acta Crystallographica Section E (2007) 63, 8 o3603-o3603
a=10.3292(4)Å b=24.1165(9)Å c=15.0923(5)Å
α=90.00° β=109.7820(10)° γ=90.00°
Β-Arteether
C17H28O5
Acta Crystallographica Section E (2008) 64, 3 o585-o586
a=10.0253(6)Å b=10.0253(6)Å c=28.628(3)Å
α=90.00° β=90.00° γ=120.00°
(E)-3-(3-Bromophenyl)-1-(4-methylphenyl)prop-2-en-1-one
C16H13BrO
Acta Crystallographica Section E (2008) 64, 11 o2238
a=5.8984(16)Å b=7.3015(19)Å c=15.559(4)Å
α=83.461(5)° β=87.860(4)° γ=88.446(5)°
<i>rac</i>-Ethyl 3-(3-bromo-2-thienyl)-2-oxo-6-(4-propoxyphenyl)cyclohex-3-ene-1-carboxylate
C22H23BrO4S
Acta Crystallographica Section E (2008) 64, 11 o2152
a=8.809(3)Å b=11.878(2)Å c=20.178(7)Å
α=92.66(2)° β=94.61(2)° γ=90.16(2)°
Flunarizinium nicotinate
C26H27F2N2,C6H4NO2
Acta Crystallographica Section C (2014) 70, 8
a=10.8536(4)Å b=10.8103(4)Å c=11.3901(4)Å
α=90° β=92.717(2)° γ=90°
Flunarizinediium bis(4-toluenesulfonate) dihydrate
C26H28F2N22,2(C7H7O3S),2H2O
Acta Crystallographica Section C (2014) 70, 8
a=10.0546(5)Å b=14.8338(6)Å c=26.9437(12)Å
α=90° β=106.497(3)° γ=90°
(5<i>RS</i>,6<i>SR</i>)-6-(4-Fluorobenzoyl)-5-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5,6-dihydro-4<i>H</i>-1,3,4-oxadiazine <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C22H16F2N2O3,C3H7NO
Acta Crystallographica Section C (2014) 70, 9
a=17.5182(7)Å b=7.4306(3)Å c=17.5595(7)Å
α=90° β=101.252(4)° γ=90°
(1<i>RS</i>,2<i>SR</i>,3<i>SR</i>,4<i>RS</i>,5<i>RS</i>)-3,5-Bis(4-fluorophenyl)-2,4-bis(pyridine-2-carbonyl)1-(pyridin-2-yl)cyclohexanol
C35H27F2N3O3
Acta Crystallographica Section C (2014) 70, 10 953-959
a=21.8864(9)Å b=11.2268(4)Å c=24.2670(9)Å
α=90° β=90° γ=90°
(1<i>RS</i>,2<i>SR</i>,3<i>SR</i>,4<i>RS</i>,5<i>RS</i>)- 3,5-Bis(4-bromophenyl)-2,4-bis(pyridine-2-carbonyl)-1-(pyridin-2-yl)cyclohexanol
C35H27Br2N3O3
Acta Crystallographica Section C (2014) 70, 10 953-959
a=9.5741(4)Å b=10.7061(3)Å c=15.9952(6)Å
α=92.863(3)° β=97.443(3)° γ=103.618(3)°
(1<i>RS</i>,2<i>SR</i>,3<i>SR</i>,4<i>RS</i>,5<i>RS</i>)-3,5-Bis(4-chlorophenyl)-2,4-bis(pyridine-2-carbonyl)-1-(pyridin-2-yl)cyclohexanol acetone 0.951-solvate
C35H27Cl2N3O3,0.951(C3H6O)
Acta Crystallographica Section C (2014) 70, 10 953-959
a=16.5446(6)Å b=53.4204(17)Å c=15.5857(4)Å
α=90° β=90° γ=90°
(2<i>E</i>)-3-(6-Methoxynaphthalen-2-yl)-1-(pyridin-3-yl)prop-2-en-1-one
C19H15NO2
Acta Crystallographica Section C (2014) 70, 11 1011-1016
a=14.2636(6)Å b=16.6789(6)Å c=6.0084(2)Å
α=90° β=90° γ=90°
(<i>RS</i>)-2-Amino-4-(6-methoxynaphthalen-2-yl)-6-(pyridin-3-yl)-3,4-dihydropyrimidine monohydrate
C20H18N4O,H2O
Acta Crystallographica Section C (2014) 70, 11 1011-1016
a=17.2244(5)Å b=5.9552(2)Å c=18.5173(6)Å
α=90° β=112.8300(10)° γ=90°
(2<i>E</i>)-1-(2,4-Dichlorophenyl)-3-[4-(prop-1-en-2-yl)phenyl]prop-2-en-1-one
C18H14Cl2O
Acta Crystallographica Section C (2015) 71, 7
a=13.4314(4)Å b=8.2405(4)Å c=29.9252(9)Å
α=90° β=90° γ=90°
(5<i>RS</i>)-3-(4-Chlorophenyl)-5-[4-(propan-2-yl)phenyl]cyclohex-2-en-1-one
C21H21ClO
Acta Crystallographica Section C (2015) 71, 7
a=6.6259(8)Å b=8.6868(11)Å c=30.472(4)Å
α=90° β=91.765(4)° γ=90°
2,3-dibromo-1,3-diphenylpropan-1-one
C15H12Br2O
Acta Crystallographica Section C (2005) 61, 12 o728-o730
a=20.6762(7)Å b=7.2443(2)Å c=10.3501(3)Å
α=90.00° β=116.575(2)° γ=90.00°
Trityl losartan
C41H37ClN6O
Acta Crystallographica Section C (2004) 60, 11 o821-o823
a=8.6962(3)Å b=20.5493(6)Å c=21.7392(5)Å
α=69.597(2)° β=88.587(2)° γ=78.962(3)°
Ethyl (4<i>RS</i>)-4-(4-benzyloxyphenyl)-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C21H22N2O3S
Acta Crystallographica Section C (2015) 71, 1
a=11.0094(4)Å b=12.7915(5)Å c=14.5418(5)Å
α=85.567(2)° β=83.815(2)° γ=69.150(2)°
Ethyl (4<i>RS</i>)-4-(4-methoxyphenyl)-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate 0.105-hydrate
C15H18N2O3S,0.105(H2O)
Acta Crystallographica Section C (2015) 71, 1
a=18.1455(6)Å b=7.3171(2)Å c=25.0493(8)Å
α=90° β=102.0080(10)° γ=90°
10,11-dihydrocarbamazepine
C15H14N2O
Acta Crystallographica Section C (2006) 62, 5 o240-o242
a=9.0592(4)Å b=10.3156(5)Å c=25.0534(12)Å
α=90.00° β=90.00° γ=90.00°
Perhydro-pyrrolo-benzofuran
C19H27NO3
Acta Crystallographica Section C (2006) 62, 5 o277-o280
a=9.4708(2)Å b=10.2139(2)Å c=10.7512(2)Å
α=105.8040(10)° β=99.1410(10)° γ=116.3200(10)°
Perhydro-pyrrolo-benzofuran
C19H21NO3
Acta Crystallographica Section C (2006) 62, 5 o277-o280
a=7.2348(2)Å b=10.1212(5)Å c=11.6287(6)Å
α=77.031(2)° β=79.285(3)° γ=76.872(3)°
Perhydro-pyrrolo-benzofuran
C18H20N2O3
Acta Crystallographica Section C (2006) 62, 5 o277-o280
a=7.2330(2)Å b=9.8165(3)Å c=11.6008(3)Å
α=78.541(2)° β=78.992(2)° γ=77.3020(10)°
1-chloroacetyl-3-ethyl-2,6-diphenylpiperidin-4-one oxime
C21H23ClN2O2
Acta Crystallographica Section C (2010) 66, 6 o274-o278
a=34.176(3)Å b=9.1227(9)Å c=12.1235(11)Å
α=90.00° β=91.962(8)° γ=90.00°
1-chloroacetyl-3-ethyl-2,6-diphenylpiperidin-4-one oxime
C21H23ClN2O2
Acta Crystallographica Section C (2010) 66, 6 o274-o278
a=33.849(3)Å b=9.0250(10)Å c=11.9800(10)Å
α=90.00° β=92.510(10)° γ=90.00°
1-chloroacetyl-2,6-diphenyl-3-(propan-2-yl)piperidin-4-one oxime
C22H25ClN2O2
Acta Crystallographica Section C (2010) 66, 6 o274-o278
a=9.4690(10)Å b=16.658(2)Å c=12.653(2)Å
α=90.00° β=90.290(10)° γ=90.00°
(S)-(+)-3-[5-cyano-2-(4-fluorophenyl)-1,3-dihydroisobenzofuran-2- yl]propanaminium oxalate oxalic acid 0.325-hydrate
2(C20H22FN2O),C2O42,C2H2O4,0.325(H2O)
Acta Crystallographica Section C (2007) 63, 2 o129-o131
a=7.9355(3)Å b=24.7376(9)Å c=11.1332(5)Å
α=90.00° β=106.589(2)° γ=90.00°
Amitriptylinium picrate
C20H24N,C6H2N3O7
Acta Crystallographica Section C (2007) 63, 9 o546-o548
a=10.0649(11)Å b=11.0187(12)Å c=12.0352(13)Å
α=73.357(2)° β=79.305(3)° γ=85.411(4)°
Nitrobenzene derivative
C7H7Cl2N2O2,Cl
Acta Crystallographica Section C (2006) 62, 1 o36-o38
a=6.889(7)Å b=12.116(12)Å c=13.286(13)Å
α=102.128(15)° β=100.939(16)° γ=103.523(16)°
2-butyl-4-chloro-1-(6-methyl-1,3-benzodioxol-5-ylmethyl)-1H-imidazole- 5-carboxaldehyde
C17H19ClN2O3
Acta Crystallographica Section C (2005) 61, 3 o177-o180
a=12.4899(5)Å b=9.4887(3)Å c=14.1018(5)Å
α=90.00° β=94.3190(10)° γ=90.00°
1-(2-bromo-4,5-dimethoxybenzyl)-2-butyl-4-chloro-1H-imidazole-5-carboxaldehyde
C17H20BrClN2O3
Acta Crystallographica Section C (2005) 61, 3 o177-o180
a=8.547(2)Å b=10.308(2)Å c=10.611(2)Å
α=91.654(4)° β=100.667(4)° γ=93.623(3)°
(+-)-Ethyl 6-(6-methoxy-2-naphthyl)-4-(4-methylphenyl)-2-oxocyclohex-3-ene-1-carboxylate
C27H26O4
Acta Crystallographica Section E (2009) 65, 6 o1186
a=18.8013(10)Å b=11.3604(6)Å c=10.2356(6)Å
α=90.00° β=93.430(2)° γ=90.00°
(E)-3-(4-Bromophenyl)-1-(3,4-dichlorophenyl)prop-2-en-1-one
C15H9BrCl2O
Acta Crystallographica Section E (2009) 65, 4 o836
a=5.9370(5)Å b=7.7365(6)Å c=14.8254(11)Å
α=81.347(6)° β=88.182(6)° γ=88.315(6)°
4-(4-Carboxybenzyl)-1-methylpiperazin-1-ium picrate
C13H19N2O2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 3 o518
a=7.3020(12)Å b=9.5993(16)Å c=15.131(3)Å
α=86.448(2)° β=79.145(2)° γ=79.950(2)°
2-Bromo-<i>N</i>'-[(2<i>Z</i>)-butan-2-ylidene]-5-methoxybenzohydrazide
C12H15BrN2O2
Acta Crystallographica Section E (2009) 65, 11 o2968-o2969
a=8.09420(10)Å b=14.2475(2)Å c=11.2974(2)Å
α=90.00° β=91.1519(13)° γ=90.00°
(4-Bromophenyl)(1<i>H</i>-indol-7-yl)methanone
C15H10BrNO
Acta Crystallographica Section E (2009) 65, 11 o2933
a=11.3241(4)Å b=7.4651(3)Å c=14.9579(5)Å
α=90.00° β=103.100(4)° γ=90.00°
5-{5-Chloro-3-[4-(methylsulfonyl)phenyl]-2-pyridyl}-2-methylpyridinium 2,4,6-trinitrophenolate
C18H16ClN2O2S,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 1 o107-o108
a=9.02500(10)Å b=12.74960(10)Å c=21.8011(3)Å
α=90.00° β=98.1140(10)° γ=90.00°
Enrofloxacinium picrate
C19H23FN3O3,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 2 o432-o433
a=7.2111(7)Å b=12.5766(7)Å c=16.2362(4)Å
α=105.556(2)° β=96.367(6)° γ=96.223(7)°
3-(2-Chloroethyl)-2-methyl-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-4-one
C11H11ClN2O
Acta Crystallographica Section E (2009) 65, 8 o1987-o1988
a=4.2546(4)Å b=11.6274(10)Å c=20.604(2)Å
α=90.00° β=90.00° γ=90.00°
2-Bromo-N'-[(Z)-2-bromobenzylidene]-5-methoxybenzohydrazide
C15H12Br2N2O2
Acta Crystallographica Section E (2009) 65, 8 o1750
a=14.768(5)Å b=12.753(4)Å c=8.227(3)Å
α=90.00° β=96.114(4)° γ=90.00°
(2<i>E</i>)-3-(3-Bromophenyl)-1-(4-chlorophenyl)prop-2-en-1-one
C15H10BrClO
Acta Crystallographica Section E (2009) 65, 8 o1915
a=14.7421(10)Å b=6.1024(4)Å c=15.1874(10)Å
α=90.00° β=103.905(2)° γ=90.00°
2-Amino-5-nitrophenyl 2-chlorophenyl ketone
C13H9ClN2O3
Acta Crystallographica Section E (2009) 65, 8 o1908-o1909
a=10.6120(3)Å b=11.3314(3)Å c=10.8456(3)Å
α=90.00° β=108.399(3)° γ=90.00°
(2<i>E</i>)-1-(4-fluorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
C18H17FO4
Acta Crystallographica Section E (2009) 65, 8 o1965-o1966
a=12.4250(2)Å b=8.62800(10)Å c=14.9038(2)Å
α=90.00° β=98.3217(12)° γ=90.00°
6-{[(Benzyloxy)carbonyl]oxy}-2-methylhexahydropyrano[3,2-<i>d</i>][1,3]dioxin-7,8-diyl bis(chloroacetate)
C20H22Cl2O10
Acta Crystallographica Section E (2010) 66, 3 o572-o573
a=8.17800(10)Å b=14.9165(3)Å c=19.3555(4)Å
α=90.00° β=90.00° γ=90.00°
4-(4-Chlorophenyl)piperidin-4-ol
C11H14ClNO
Acta Crystallographica Section E (2010) 66, 3 o562
a=11.3706(10)Å b=9.5204(8)Å c=10.6164(9)Å
α=90.00° β=108.458(8)° γ=90.00°
Orphenadrinium picrate picric acid
C18H24NO,C6H2N3O7,C6H3N3O7
Acta Crystallographica Section E (2010) 66, 3 o682-o683
a=11.1914(9)Å b=12.4481(10)Å c=22.6127(19)Å
α=90.00° β=93.6010(10)° γ=90.00°
Bis[4-(4-chlorophenyl)-4-hydroxypiperidinium] dipicrate dimethyl sulfoxide solvate
2(C11H15ClNO),2(C6H2N3O7),C2H6OS
Acta Crystallographica Section E (2010) 66, 5 o1212-o1213
a=8.9207(4)Å b=18.1230(9)Å c=12.9886(6)Å
α=90.00° β=98.4300(10)° γ=90.00°
Lansoprazole intermediate--chloranilic acid (2:1)
2(C16H15F3N3OS),C6Cl2O42
Acta Crystallographica Section E (2010) 66, 6 o1507-o1508
a=9.48575(8)Å b=23.6316(2)Å c=17.86775(15)Å
α=90.00° β=100.2065(9)° γ=90.00°
3,5-Bis(4-bromophenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C21H16Br2N2
Acta Crystallographica Section E (2010) 66, 6 o1279-o1280
a=10.5815(3)Å b=11.2119(3)Å c=15.4569(4)Å
α=90° β=90° γ=90°
(1<i>E</i>)-1-(3-Bromophenyl)ethanone 2,4-dinitrophenylhydrazone
C14H11BrN4O4
Acta Crystallographica Section E (2010) 66, 11 o2832-o2833
a=7.7546(9)Å b=13.4362(15)Å c=14.1884(16)Å
α=91.894(2)° β=90.553(2)° γ=97.128(2)°
<i>N</i>-[(2-Chloro-3-quinolyl)methyl]-4-fluoroaniline
C16H12ClFN2
Acta Crystallographica Section E (2010) 66, 10 o2548-o2549
a=7.3661(8)Å b=8.8967(9)Å c=11.5129(12)Å
α=68.7040(10)° β=74.4680(10)° γ=75.4450(10)°
2-(4-Chlorophenyl)-6-methoxychroman-4-one
C16H13ClO3
Acta Crystallographica Section E (2010) 66, 10 o2546-o2547
a=5.0188(3)Å b=12.0138(7)Å c=12.3708(7)Å
α=108.035(5)° β=98.379(4)° γ=91.820(5)°
Fluconazolium picrate
C13H13F2N6O,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 10 o2568
a=5.6470(10)Å b=17.347(2)Å c=22.571(2)Å
α=90.00° β=94.270(10)° γ=90.00°
(2<i>E</i>)-3-(2-Anthracen-2-yl)-1-(2-hydroxyphenyl)prop-2-en-1-one
C23H16O2
Acta Crystallographica Section E (2011) 67, 4 o795
a=14.0748(5)Å b=13.7362(5)Å c=16.9800(8)Å
α=90.00° β=101.487(5)° γ=90.00°
(2<i>E</i>)-3-{4-[(1<i>H</i>-1,3-Benzimidazol-2-yl)methoxy]-3-ethoxyphenyl}- 1-(4-bromophenyl)prop-2-en-1-one monohydrate
C25H21BrN2O3,H2O
Acta Crystallographica Section E (2011) 67, 4 o834-o835
a=13.8406(12)Å b=16.5192(8)Å c=19.4719(13)Å
α=90.00° β=90.00° γ=90.00°
3,5-Bis(4-methylphenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C23H22N2
Acta Crystallographica Section E (2011) 67, 4 o1019
a=5.8113(3)Å b=10.6959(5)Å c=28.4455(13)Å
α=90° β=94.983(4)° γ=90°
1-(2,5-Dichloro-3-thienyl)ethanone
C6H4Cl2OS
Acta Crystallographica Section E (2010) 66, 10 o2480
a=13.0980(3)Å b=7.17900(10)Å c=16.3290(3)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-3-(4-Chlorophenyl)-1-(1-naphthyl)prop-2-en-1-one
C19H13ClO
Acta Crystallographica Section E (2009) 65, 12 o3255-o3256
a=12.0392(14)Å b=8.0544(5)Å c=7.8472(6)Å
α=90.00° β=98.091(10)° γ=90.00°
<i>N</i>,<i>N</i>'-Bis[(<i>E</i>)-2-fluorobenzylidene]-1-(2- fluorophenyl)methanediamine
C21H15F3N2
Acta Crystallographica Section E (2010) 66, 2 o422-o423
a=8.0215(5)Å b=9.3740(4)Å c=11.9744(6)Å
α=99.184(4)° β=93.179(5)° γ=108.165(5)°
4,6-Dichloro-5-methoxypyrimidine
C5H4Cl2N2O
Acta Crystallographica Section E (2010) 66, 2 o408
a=13.6545(19)Å b=3.9290(6)Å c=13.0275(18)Å
α=90.00° β=90.00° γ=90.00°
Chloranilic acid
C6H2Cl2O4
Acta Crystallographica Section E (2010) 66, 2 o497-o498
a=7.5338(12)Å b=5.5225(10)Å c=8.5720(12)Å
α=90.00° β=104.868(11)° γ=90.00°
4-(Methylsulfonyl)piperazin-1-ium chloride
C5H13N2O2S,Cl
Acta Crystallographica Section E (2010) 66, 2 o361-o362
a=6.02310(10)Å b=9.1097(2)Å c=7.9852(2)Å
α=90.00° β=100.7000(10)° γ=90.00°
2,4-Dichloro-1-[1-(2,4-dichlorobenzyloxy)ethyl]benzene
C15H12Cl4O
Acta Crystallographica Section E (2010) 66, 1 o165-o166
a=9.3755(4)Å b=9.9229(4)Å c=9.9667(4)Å
α=62.313(3)° β=70.246(4)° γ=71.467(4)°
Desipramine hydrochloride
C18H23N2,Cl
Acta Crystallographica Section E (2010) 66, 3 o674-o675
a=10.7258(3)Å b=15.9997(6)Å c=20.6088(8)Å
α=107.347(3)° β=89.960(2)° γ=99.414(2)°
Pefloxacinium picrate
C17H21FN3O3,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 3 o714-o715
a=7.26450(10)Å b=9.1987(2)Å c=20.2253(4)Å
α=77.1160(10)° β=81.3150(10)° γ=67.1240(10)°
(2<i>E</i>)-1-(2-Bromophenyl)-3-(4-bromophenyl)prop-2-en-1-one
C15H10Br2O
Acta Crystallographica Section E (2010) 66, 7 o1701
a=5.6988(5)Å b=9.5462(9)Å c=23.8532(15)Å
α=90.00° β=91.021(8)° γ=90.00°
(2<i>E</i>)-1-(2-Bromophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
C18H17BrO4
Acta Crystallographica Section E (2010) 66, 7 o1676
a=9.9616(4)Å b=13.6020(13)Å c=24.4162(17)Å
α=90.00° β=90.00° γ=90.00°
(1<i>RS</i>,6<i>SR</i>)-Ethyl 4,6-bis(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate
C21H18F2O3
Acta Crystallographica Section E (2011) 67, 2 o336
a=11.062(2)Å b=11.675(3)Å c=13.854(3)Å
α=90.00° β=92.89(2)° γ=90.00°
Cinnarizinium dipicrate
C26H30N22,2(C6H2N3O7)
Acta Crystallographica Section E (2011) 67, 2 o500-o501
a=15.1987(2)Å b=10.09130(17)Å c=25.0724(3)Å
α=90.00° β=95.9170(14)° γ=90.00°
(1<i>RS</i>,6<i>SR</i>)-Ethyl 4-(2,4-dichlorophenyl)-6-(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate
C21H17Cl2FO3
Acta Crystallographica Section E (2011) 67, 2 o445-o446
a=32.321(5)Å b=5.437(2)Å c=22.309(3)Å
α=90.00° β=90.00° γ=90.00°
(<i>RS</i>)-4-(3-carboxy-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydroquinolin-7-yl)- 2-methylpiperazin-1-ium 2,4,6-trinitrophenolate
C17H20F2N3O3,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 2 o483-o484
a=10.9314(4)Å b=11.6748(4)Å c=12.0530(4)Å
α=92.969(3)° β=115.555(3)° γ=109.852(3)°
1-methylpiperazine-1,4-diium dipicrate
C5H14N22,2(C6H2N3O7)
Acta Crystallographica Section E (2011) 67, 2 o390-o391
a=8.2001(12)Å b=10.1780(15)Å c=13.7399(18)Å
α=89.798(12)° β=78.130(11)° γ=81.558(12)°
(1<i>RS</i>,6<i>SR</i>)-Ethyl 4-(4-chlorophenyl)-6-(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate toluene hemisolvate
C21H18ClFO3,0.5(C7H8)
Acta Crystallographica Section E (2011) 67, 2 o334-o335
a=7.572(2)Å b=11.259(3)Å c=13.362(3)Å
α=69.42(2)° β=86.58(2)° γ=70.98(2)°
Ethylenediammonium dipicrate dihydrate
C2H10N22,2(C6H2N3O7),2(H2O)
Acta Crystallographica Section E (2011) 67, 3 o637-o638
a=13.4795(4)Å b=20.4372(7)Å c=8.0410(3)Å
α=90.00° β=90.00° γ=90.00°